Attached files
| file | filename |
|---|---|
| EX-99.B - EXHIBIT 99B - MERA PHARMACEUTICALS INC | e3086_ex99b.htm |
| 8-K - FORM 8-K - MERA PHARMACEUTICALS INC | e3086_8-k.htm |
EXHIBIT 99a
Mera Pharmaceuticals, Inc.
Balance Sheet
As of September 8, 2021
| Sep 8, 21 | ||||
| ASSETS | 0.00 | |||
| LIABILITIES & EQUITY | ||||
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts Payable | ||||
| Accounts Payable | 38,649.08 | |||
| Total Accounts Payable | 38,649.08 | |||
| Total Current Liabilities | 38,649.08 | |||
| Total Liabilities | 38,649.08 | |||
| Equity | ||||
| Preferred Stock - Series A | 1.00 | |||
| Preferred Stock - Series B | 1.00 | |||
| Common Stock | 54,777.00 | |||
| Additional Paid-in Capital | 7,968,873.00 | |||
| Treasury Stock | -2,025.00 | |||
| Retained Earnings | -8,052,317.00 | |||
| Net Income | -7,959.08 | |||
| Total Equity | -38,649.08 | |||
| TOTAL LIABILITIES & EQUITY | 0.00 | |||